Health
Why Might Cassava Succeed With Its Alzheimer’s Drug, When So Many Have Failed? – The Motley Fool
Alzheimer’s research has been hampered by apparently mistaken ideas about what causes the disease. Cassava has a new theory about…
Cassava Sciences(NASDAQ:SAVA) is like any other unprofitable biotech — it has a drug in clinical trials, and its investors are hoping the drug works so they can make a lot of money. What makes Cassava really interesting is that it’s zigging where Big Pharma…
-
Noosa News13 hours agoWhat has the premier changed about the Queensland government logo? Take the Brisbane Times Quiz
-
General13 hours agoMatildas vs Slovenia live updates — blog, scores and stats from friendly at Perth Rectangular Stadium
-
Business18 hours agoGuess which ASX mining stock is up 8% today and could rocket a further 200%
-
General19 hours agoCassius Turvey’s mother Mechelle details trauma at sentencing hearing for son’s murderers